Litcius/Paper detail

DCLK1 autoinhibition and activation in tumorigenesis

Linna Cheng, Zejing Yang, Wenhao Guo, Chengyong Wu, Shufang Liang, Aiping Tong, Zhongwei Cao, Rick F. Thorne, Shengyong Yang, Yamei Yu, Qiang Chen

2021The Innovation38 citationsDOIOpen Access PDF

Abstract

-dependent manner, which releases the autoinhibition. We also analyzed cancer-associated mutations occurring in the AID and elucidate how these mutations disrupt DCLK1 autoinhibition to elicit kinase activity upregulation. Our results present a molecular mechanism for autoinhibition and activation of DCLK1 kinase activity and provide insights into DCLK1-associated tumorigenesis.

Topics & Concepts

CarcinogenesisKinaseDownregulation and upregulationProtein kinase domainCell biologyBiologyActivator (genetics)ChemistryBiochemistryMutantGeneCancer, Hypoxia, and MetabolismHippo pathway signaling and YAP/TAZNeuroblastoma Research and Treatments
DCLK1 autoinhibition and activation in tumorigenesis | Litcius